Skip to main content
SpringerLink
Log in

Albuminuria in Non-Insulin-Dependent Diabetes — Renal or Extrarenal Disease?

  • Chapter
The Kidney and Hypertension in Diabetes Mellitus

  • 110 Accesses

Abstract

Microalbuminuria and overt proteinuria in IDDM have been decisively established as indicators of various stages in diabetic renal disease. Persistent microalbuminuria defines the stage of ‘incipient nephropathy’, that is the stage that heralds progression to overt nephropathy in more than 80 percent of cases within a decade, with proteinuria and relentless decline in kidney function, unless intervention is undertaken. Subsequently an expanding research concerning patients with non-insulin-dependent diabetes (NIDDM) has clearly demonstrated, that the course of complications and the implication of albuminuria differ in several respects between the two types of diabetes [1–3].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Mogensen CE, Schmitz O. The diabetic kidney: From hyperfiltration and microalbuminuria to end-stage renal failure. Med Clin North Am 1988; 72: 1465–1492.

    CAS  PubMed  Google Scholar 

  2. Mogensen CE, Damsgaard EM, Frøland A, Nielsen S, de Fine Olivarius N, Schmitz A. Microalbuminuria in non-insulin-dependent diabetes. Clin Nephrol 1992; 38: s28–s39.

    PubMed  Google Scholar 

  3. Schmitz A. The kidney in non-insulin-dependent diabetes. Studies on glomerular structure and function and the relationship between microalbuminuria and mortality. Acta Diabetol 1992; 29: 47–69.

    Google Scholar 

  4. Fabre J, Balant LP, Dayer PG, Fox HM, Vernet AT. The kidney in maturity onset diabetes mellitus: A clinical study of 510 patients. Kidney Int 1982; 21: 730–738.

    Article  CAS  PubMed  Google Scholar 

  5. Schmitz A, Væth M. Microalbuminuria: A major risk factor in non-insulin-dependent diabetes. A 10-year follow-up study of 503 patients. Diabetic Med 1988; 5: 126–134.

    CAS  Google Scholar 

  6. Gall M-A, Rossing P, Skøtt P, Damsbo P, Vaag A, Bech K, Dejgaard A, Lauritzen M, Lauritzen E, Hougaard P, Beck-Nielsen H, Parving H-H. Prevalence of micro-and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European Type 2 (non-insulin-dependent) diabetic patients. Diabetologia 1991; 34: 655–661.

    Article  CAS  PubMed  Google Scholar 

  7. Marshall SM, Alberti KGMM. Comparison of the prevalence and associated features of abnormal albumin excretion in insulin-dependent and non-insulin-dependent diabetes. Q J Med 1989; 70: 61–71.

    CAS  PubMed  Google Scholar 

  8. Damsgaard EM. »Prevalence and incidence of microalbuminuria in non-insulin-dependent diabetes: Relations to other vascular lesions.« In The Kidney and Hypertension in Diabetes Mellitus, 1.ed., C.E. Mogensen, ed. Boston: Martinus Nijhoff Publishing, 1988; pp 59–63.

    Google Scholar 

  9. Olivarius N de F, Andreasen AH, Keiding N, Mogensen CE. Epidemiology of renal involvement in newly-diagnosed middle-aged and elderly diabetic patients. Cross-sectional data from the population-based study “Diabetes care in General Practice”, Denmark. Diabetologia 1993; 36: 1007–1016.

    Google Scholar 

  10. Standi E, Stiegler H. Microalbuminuria in a random cohort of recently diagnosed Type 2 (non-insulin-dependent) diabetic patients living in the Greater Munich area. Diabetologia 1993; 36: 1017–1020.

    Article  Google Scholar 

  11. Ballard DJ, Humphrey LL, Melton LJ III, Frohnert PP, Chu C-P, O’Fallon WM, Palumbo PJ. Epidemiology of persistent proteinuria in type II diabetes mellitus. Population-based study in Rochester, Minnesota. Diabetes 1988; 37: 405–412.

    CAS  Google Scholar 

  12. Schmitz A, Hvid Hansen H, Christensen T. Kidney function in newly diagnosed Type 2 (non-insulin-dependent) diabetic patients, before and during treatment. Diabetologia 1989; 32: 434–439.

    Article  CAS  PubMed  Google Scholar 

  13. Uusitupa M, Siitonen O, Penttilä I, Aro A, Pyörälä K. Proteinuria in newly diagnosed type II diabetic patients. Diabetes Care 1987; 10: 191–194.

    Article  CAS  PubMed  Google Scholar 

  14. Martin P, Hampton KK, Walton C, Tindall H, Daview JA. Microproteinuria in Type 2 diabetes mellitus from diagnosis. Diabetic Med 1990; 7: 315–318.

    Article  CAS  PubMed  Google Scholar 

  15. Patrick AW, Leslie PJ, Clarke BF, Frier BM. The natural history and associations of microalbuminuria in type 2 diabetes during the first year after diagnosis. Diabetic Med 1990; 7: 902–908.

    Article  CAS  PubMed  Google Scholar 

  16. Tung P, Levin SR. Nephropathy in non-insulin-dependent diabetes mellitus. Am J Med 1988; 85: Suppl 5A: 131–136.

    Article  CAS  PubMed  Google Scholar 

  17. Mauer SM, Chavers BM. »A comparison of kidney disease in Type 1 and Type II diabetes.« In Comparison of Type I and Type II Diabetes. Similarities and dissimilarities in etiology, pathogenesis, and complications, M. Vranic, C.H. Hollenberg, G. Steiner, eds. New York, London: Plenum Press, 1985; pp 299–303.

    Chapter  Google Scholar 

  18. Rosansky SJ, Eggers PW. Trends in the US end-stage renal disease population: 1973–1983. Am J Kidney Dis 1987; 9: 91–97.

    CAS  PubMed  Google Scholar 

  19. Brunner FP, Brynger H, Challah S, Fassbinder W, Geerlings W, Selwood NH, Tufveson G, Wing AJ. Renal replacement therapy in patients with diabetic nephropathy, 1980–1985. Report from the European Dialysis and Transplant Association Registry. Nephrol Dial Transplant 1988; 3: 585–595.

    CAS  Google Scholar 

  20. Jarrett RJ, Viberti GC, Argyropoulos A, Hill RD, Mahmud U, Murrells TJ. Microalbuminuria predicts mortality in non-insulin-dependent diabetes. Diabetic Med 1984; 1: 17–19.

    Article  CAS  PubMed  Google Scholar 

  21. Mogensen CE. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 1984; 310: 356–360.

    Article  CAS  PubMed  Google Scholar 

  22. Mogensen CE, Chachati A, Christensen CK, Close CF, Deckert T, Hommel E, Kastrup J, Lefebvre P, Mathiesen ER, Feldt-Rasmussen B, Schmitz A, Viberti GC. Microalbuminuria: an early marker of renal involvement in diabetes. Uremia Invest 1985–86; 9: 85–95.

    PubMed  Google Scholar 

  23. Miles DW, Mogensen CE, Gundersen HJG. Radioimmunoassay for urinary albumin using a single antibody. Scand J Clin Lab Invest 1970; 26: 5–11.

    Article  CAS  PubMed  Google Scholar 

  24. Mattock MB, Morrish NJ, Viberti GC, Keen H, Fitzgerald AP, Jackson G. Prospective study of microalbuminuria as predictor of mortality in NIDDM. Diabetes 1992; 41: 736–741.

    Article  CAS  PubMed  Google Scholar 

  25. Damsgaard EM, Frøland A, Jørgensen OD, Mogensen CE. Eight to nine year mortality in known non-insulin dependent diabetics and controls. Kidney Int 1992; 41: 731–735.

    Article  CAS  PubMed  Google Scholar 

  26. Neil A, Hawkins M, Potok M, Thorogood M, Cohen D, Mann J. A prospective population-based study of microalbuminuria as a predictor of mortality in NIDDM. Diabetes Care 1993; 16: 996–1004.

    Article  CAS  PubMed  Google Scholar 

  27. MacLeod JM, Lutale J, Marshall SM. Albumin excretion and vascular deaths in NIDDM. Diabetologia 1995; 38: 610–616.

    Article  CAS  PubMed  Google Scholar 

  28. Gall M-A, Borch-Johnsen K, Hougaard P, Nielsen FS, Parving HH. Albuminuria and poor glycemic control predict mortality in NIDDM. Diabetes 1995; 44: 1303–1309.

    Article  CAS  PubMed  Google Scholar 

  29. Schmitz A. Renal function changes in middle-aged and elderly Caucasian Type 2 (non-insulin-dependent) diabetic patients — a review. Diabetologia 1993; 36: 985–992.

    Article  CAS  PubMed  Google Scholar 

  30. Damsgaard EM, Mogensen CE. Microalbuminuria in elderly hyperglycaemic patients and controls. Diabetic Med 1986; 3: 430–435.

    Article  CAS  PubMed  Google Scholar 

  31. Hostetter TH, Rennke HG, Brenner BM. The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies. Am J Med 1982; 72: 375–380.

    Article  CAS  PubMed  Google Scholar 

  32. Schmitz A. Increased urinary haemoglobin in diabetics with microalbuminuria — measured by an ELISA. Scand J Clin Lab Invest 1990; 50: 303–308.

    Article  CAS  PubMed  Google Scholar 

  33. Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A. Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia 1989; 32: 219–226.

    CAS  Google Scholar 

  34. Mattock MB, Keen H, Viberti GC, El-Gohari MR, Murrells TJ, Scott GS, Wing JR, Jackson PG. Coronary heart disease and urinary albumin excretion rate in type 2 (non-insulin-dependent) diabetic patients. Diabetologia 1988; 31: 82–87.

    Article  CAS  PubMed  Google Scholar 

  35. Eiskjær H, Bagger JP, Mogensen CE, Schmitz A, Pedersen EB. Enhanced urinary excretion of albumin in congestive heart failure: effect of ACE-inhibition. Scand J Clin Lab Invest 1992; 52: 193–199.

    Article  PubMed  Google Scholar 

  36. Kelbæk H, Jensen T, Feldt-Rasmussen B, Christensen NJ, Richter EA, Deckert T, Nielsen SL. Impaired left-ventricular function in insulin-dependent diabetic patients with increased urinary albumin excretion. Scand J Clin Lab Invest 1991; 51: 467–473.

    Article  PubMed  Google Scholar 

  37. Keen H. »Macrovascular disease in diabetes mellitus.« In Diabetic Complications: Early Diagnosis and Treatment, D. Andreani, G. Crepaldi, U. Di Mario, G. Pozza, eds. John Wiley & Sons Ltd., 1987; pp 3-12.

    Google Scholar 

  38. Jensen T. Albuminuria — a marker of renal and generalized vascular disease in insulin-dependent diabetes mellitus (thesis). Copenhagen: København: Lægeforeningens Forlag, 1991.

    Google Scholar 

  39. Winocour PH, Durrington PN, Ishola M, Anderson DC, Cohen H. Influence of proteinuria on vascular disease, blood pressure, and lipoproteins in insulin dependent diabetes mellitus. BMJ 1987; 294: 1648–1651.

    Article  CAS  PubMed  Google Scholar 

  40. Niskanen L, Uusitupa M, Sarlund H, Siitonen O, Voutilainen E, Penttilä I, Pyörälä K. Microalbuminuria predicts the development of serum lipoprotein abnormalities favouring atherogenesis in newly diagnosed Type 2 (non-insulin-dependent) diabetic patients. Diabetologia 1990; 33: 237–243.

    Article  CAS  PubMed  Google Scholar 

  41. Standi E, Stiegler H, Janka HU, Mehnert H. Risk profile of macrovascular disease in diabetes mellitus. Diabete Metab (Paris) 1988; 14: 505–511.

    Google Scholar 

  42. Schmitz A, Ingerslev J. Haemostatic measures in Type 2 diabetic patients with microalbuminuria. Diabetic Med 1990; 7: 521–525.

    Article  CAS  PubMed  Google Scholar 

  43. Stehouwer CDA, Nauta JJP, Zeldenrust GC, Hackeng WHL, Donker AJM, den Ottolander GJH. Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus. Lancet 1992; 340: 319–323.

    Article  CAS  PubMed  Google Scholar 

  44. Jensen T, Bjerre-Knudsen J, Feldt-Rasmussen B, Deckert T. Features of endothelial dysfunction in early diabetic nephropathy. Lancet 1989; i: 461–463.

    Article  Google Scholar 

  45. Yudkin JS. Coronary heart disease in diabetes mellitus: three new risk factors and a unifying hypothesis. J Intern Med 1995; 238: 21–30.

    Article  CAS  PubMed  Google Scholar 

  46. Damsgaard EM, Frøland A, Jørgensen OD, Mogensen CE. Microalbuminuria as a predictor of increased mortality in elderly people. BMJ 1990; 300: 297–300.

    Article  CAS  PubMed  Google Scholar 

  47. Mykkänen L, Haffner SM, Kuusisto J, Pyorälä K, Laakso M. Microalbuminuria precedes the development of NIDDM. Diabetes 1994; 43: 552–557.

    Article  PubMed  Google Scholar 

  48. Gellman DD, Pirani CL, Soothill JF, Muehrcke RC, Kark RM. Diabetic nephropathy, a clinical and pathologic study based on renal biopsies. Medicine 1959; 38: 321–367.

    CAS  PubMed  Google Scholar 

  49. Thomsen AC. The Kidney in Diabetes Mellitus (thesis). Copenhagen: Munksgaard, 1965.

    Google Scholar 

  50. Schmitz A, Gundersen HJG, Østerby R. Glomerular morphology by light microscopy in non-insulin-dependent diabetes mellitus. Lack of glomerular hypertrophy. Diabetes 1988; 37: 38–43.

    Article  CAS  Google Scholar 

  51. Østerby R, Gall M-A, Schmitz A, Nielsen FS, Nyberg G, Parving H-H. Glomerular structure and function in proteinuric Type 2 (non-insulin-dependent) diabetic patients. Diabetologia 1993; 36: 1064–1070.

    Article  PubMed  Google Scholar 

  52. Parving H-H, Gall M-A, Skøtt P, Jørgensen HE, Løkkegaard H, Jørgensen F, Nielsen B, Larsen S. Prevalence and causes of albuminuria in non-insulin-dependent diabetic patients. Kidney Int 1992; 41: 758–762.

    Article  CAS  PubMed  Google Scholar 

  53. Taft JL, Billson VR, Nankervis A, Kincaid-Smith P, Martin FIR. A clinical-histological study of individuals with diabetes mellitus and proteinuria. Diabetic Med 1990; 7: 215–221.

    Article  CAS  PubMed  Google Scholar 

  54. Keen H, Chlouverakis C, Fuller J, Jarrett RJ. The concomitants of raised blood sugar: studies in newly-detected hyperglycaemics. II: Urinary albumin excretion, blood pressure and their relation to blood sugar levels. Guys Hosp Rep 1969; 118: 247–254.

    CAS  Google Scholar 

  55. Ibsen H, Hilden T. New views on the relationship between coronary heart disease and hypertension. J Intern Med 1990; 227: 77–79.

    Article  CAS  PubMed  Google Scholar 

  56. Jensen JS, Borch-Johnsen K, Jensen G, Feldt-Rasmussen B. Microalbuminuria reflects a generalized transvascular albumin leakiness in clinically healthy subjects. Clin Sci 1995; 88: 629–633.

    CAS  PubMed  Google Scholar 

  57. Mogensen CE. Microalbuminuria as a predictor of clinical diabetic nephropathy. Kidney Int 1987; 31:673–689.

    Article  CAS  PubMed  Google Scholar 

  58. Humphrey LL, Ballard DJ, Frohnert PP, Chu C-P, O’Fallon WM, Palumbo PJ. Chronic renal failure in non-insulin-dependent diabetes mellitus. A population-based study in Rochester, Minnesota. Ann Intern Med 1989; 111: 788–796.

    CAS  Google Scholar 

  59. Schmitz A, Væth M, Mogensen CE. Systolic blood pressure relates to the rate of progression of albuminuria in NIDDM. Diabetologia 1994; 37: 1251–1258.

    Article  CAS  PubMed  Google Scholar 

  60. Kikkawa R, Haneda M. »Risk factor for progression of microalbumiuria in relatively young NIDDM-patients.« In The Kidney and Hypertension in Diabetes Mellitus, 2.ed., C.E. Mogensen, ed. Boston, Dordrecht, London: Kluwer Academic Publishers, 1994; pp 103–109.

    Chapter  Google Scholar 

  61. Melbourne Diabetic Nephropathy Study Group: Comparison between perindopril and nifedipine in hypertensive and normotensive diabetic patients with microalbuminuria. BMJ 1991; 302: 210–216.

    Article  Google Scholar 

  62. Lacourcière Y, Nadeau A, Poirier L, Tancrède G. Captopril or conventional therapy in hypertensive type-II diabetics — 3-year analysis. Hypertension 1993; 21: 786–794.

    Article  PubMed  Google Scholar 

  63. Ravid M, Savin H, Jutrin I, Bental T, Katz B, Lishner M. Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients. Ann Intern Med 1993; 118: 577–581.

    Article  CAS  PubMed  Google Scholar 

  64. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977–986.

    Article  Google Scholar 

  65. U.K. Prospective Study Group. U.K. Prospective Diabetes Study 16. Overview of 6 years’ therapy of type II Diabetes: A progressive disease. Diabetes 1995; 44: 1249–1258.

    Article  Google Scholar 

  66. Wolffenbuttel BHR, van Haeften TW. Prevention of complications in non-insulin-dependent diabetes mellitus (NIDDM). Drugs 1995; 50: 263–288.

    Article  CAS  PubMed  Google Scholar 

  67. Foote EF. Prevention and treatment of diabetic nephropathy. Am J Health-Syst Pharm 1995; 52: 1781–1792.

    CAS  PubMed  Google Scholar 

  68. Antiplatelet Trialists’ Collaboration. Collaborative overview of randomized trials of antiplatelet therapy: I. Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994; 308: 81–106.

    Google Scholar 

  69. Vedel P, Gæde P, Obel J, Parving H-H, Pedersen O. Intensive multifactorial intervention in NIDDM patients with persistent microalbuminuria (Abstract). Diabetologia 1996; 39: Suppl. 1: A308.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medical Department M, Aarhus Kommunehospital, Aarhus, Denmark

    Anita Schmitz

Authors
  1. Anita Schmitz
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Medical Department M (Diabetes & Endocrinology), Aarhus Kommunehospital University Hospitals in Aarhus, Aarhus C, Denmark

    Carl Erik Mogensen

Rights and permissions

Reprints and permissions

Copyright information

© 1996 Springer Science+Business Media New York

About this chapter

Cite this chapter

Schmitz, A. (1996). Albuminuria in Non-Insulin-Dependent Diabetes — Renal or Extrarenal Disease?. In: Mogensen, C.E. (eds) The Kidney and Hypertension in Diabetes Mellitus. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-6749-0_3

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-6749-0_3

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4757-6751-3

  • Online ISBN: 978-1-4757-6749-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation